Khandelwal Nita, Benkeser David C, Coe Norma B, Curtis J Randall
1Department of Anesthesiology and Pain Medicine, University of Washington, Harborview Medical Center, Seattle, WA. 2Department of Biostatistics, University of Washington, Seattle, WA. 3Department of Health Services, University of Washington, Seattle, WA. 4Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington, Harborview Medical Center, Seattle, WA.
Crit Care Med. 2016 Aug;44(8):1474-81. doi: 10.1097/CCM.0000000000001675.
To estimate the potential ICU-related cost savings if in-hospital advance care planning and ICU-based palliative care consultation became standard of care for patients with chronic and serious illness.
Decision analysis using literature estimates and inpatient administrative data from Premier.
Patients with chronic, life-limiting illness admitted to a hospital within the Premier network.
None.
Using Premier data (2008-2012), ICU resource utilization and costs were tracked over a 1-year time horizon for 2,097,563 patients with chronic life-limiting illness. Using a Markov microsimulation model, we explored the potential cost savings from the hospital system perspective under a variety of scenarios by varying the interventions' efficacies and availabilities. Of 2,097,563 patients, 657,825 (31%) used the ICU during the 1-year time horizon; mean ICU spending per patient was 11.3k (SD, 17.6k). In the base-case analysis, if in-hospital advance care planning and ICU-based palliative care consultation were systematically provided, we estimated a mean reduction in ICU costs of 2.8k (SD, 14.5k) per patient and an ICU cost saving of 25%. Among the simulated patients who used the ICU, the receipt of both interventions could have resulted in ICU cost savings of 1.9 billion, representing a 6% reduction in total hospital costs for these patients.
In-hospital advance care planning and palliative care consultation have the potential to result in significant cost savings. Studies are needed to confirm these findings, but our results provide guidance for hospitals and policymakers.
评估若针对患有慢性重症疾病的患者,将住院预立医疗计划及基于重症监护病房(ICU)的姑息治疗会诊作为标准治疗手段,与ICU相关的潜在成本节约情况。
利用文献估计值及来自Premier的住院管理数据进行决策分析。
Premier网络内医院收治的患有慢性、危及生命疾病的患者。
无。
利用Premier数据(2008 - 2012年),对2,097,563例患有慢性危及生命疾病的患者在1年时间范围内的ICU资源利用情况及成本进行跟踪。使用马尔可夫微观模拟模型,我们通过改变干预措施的效果和可及性,从医院系统角度探讨了在各种情景下潜在的成本节约情况。在2,097,563例患者中,657,825例(31%)在1年时间范围内使用了ICU;每位患者的平均ICU支出为11,300美元(标准差为17,600美元)。在基线分析中,如果系统地提供住院预立医疗计划和基于ICU的姑息治疗会诊,我们估计每位患者的ICU成本平均降低2,800美元(标准差为14,500美元),ICU成本节约25%。在模拟使用ICU的患者中,接受这两种干预措施可节省ICU成本19亿美元,占这些患者总住院成本的6%。
住院预立医疗计划和姑息治疗会诊有可能带来显著的成本节约。需要开展研究来证实这些发现,但我们的结果为医院和政策制定者提供了指导。